Tīpoka ki te ihirangi

Welcome to University of UNSW, Bengaluru

  • Home
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
    • Māori
  • Sign In
Whatutoto
  • Channels
Rapua ētahi atu hongere:

Kaupapa: AAV

  • Kaupapa: FXR agonists
  • Kaupapa: HBX 3′ end region
  • Kaupapa: HCV
  • Kaupapa: KLHL12 peptide
  • Kaupapa: NAFLD
  • Kaupapa: NASH
  • Kaupapa: PFIC
  • Kaupapa: PPAR agonists
  • Kaupapa: RUNX1
  • Kaupapa: autoantibodies
  • Kaupapa: biomarker
  • Kaupapa: budesonide
  • Kaupapa: cholestatic diseases
  • Kaupapa: chronic hepatitis B
  • Kaupapa: cirrhosis
  • Kaupapa: deletions
  • Kaupapa: farnesoid X receptor
  • Kaupapa: fatty liver
  • Kaupapa: females
  • Kaupapa: fibrates
  • Kaupapa: fibrosis score
  • Kaupapa: gender
  • Kaupapa: gene therapy
  • Kaupapa: genotoxicity
  • Kaupapa: glycoprotein gp210
  • Kaupapa: hepatic steatosis
  • Kaupapa: hepatitis B X open reading frame
  • Whakaatu tūemi hei hua rapu
  • Tūhuratia ngā hongere pātahi
  • Quick Look
    Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases

Kaupapa: DAA

  • Kaupapa: FXR agonists
  • Kaupapa: HBX 3′ end region
  • Kaupapa: HCV
  • Kaupapa: KLHL12 peptide
  • Kaupapa: NAFLD
  • Kaupapa: NASH
  • Kaupapa: PFIC
  • Kaupapa: PPAR agonists
  • Kaupapa: RUNX1
  • Kaupapa: autoantibodies
  • Kaupapa: biomarker
  • Kaupapa: budesonide
  • Kaupapa: cholestatic diseases
  • Kaupapa: chronic hepatitis B
  • Kaupapa: cirrhosis
  • Kaupapa: deletions
  • Kaupapa: farnesoid X receptor
  • Kaupapa: fatty liver
  • Kaupapa: females
  • Kaupapa: fibrates
  • Kaupapa: fibrosis score
  • Kaupapa: gender
  • Kaupapa: gene therapy
  • Kaupapa: genotoxicity
  • Kaupapa: glycoprotein gp210
  • Kaupapa: hepatic steatosis
  • Kaupapa: hepatitis B X open reading frame
  • Whakaatu tūemi hei hua rapu
  • Tūhuratia ngā hongere pātahi
  • Quick Look
    Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases

Ngā tūemi rite: Advances in Pathogenesis and Therapeutics of Hepatobiliary Diseases

  • Tiro pūkete
  • Tūhuratia ngā hongere pātahi
  • Quick Look
    Novel Challenges and Therapeutic Options for Liver Diseases
  • Quick Look
    New Therapies of Liver Diseases
  • Quick Look
    Hepatic Elastography Using Ultrasound Waves - Revised Edition
  • Quick Look
    Liver Research
  • Quick Look
    Editorial Board Members’ Collection Series
  • Quick Look
    A Healthy Liver Will Always Deliver!
  • Quick Look
    Recent Advances in the Diagnosis and Treatment of Chronic Liver Diseases
  • Quick Look
    Annals of Hepatology
  • Quick Look
    Hepatitis C
  • Quick Look
    Journal of Hepatocellular Carcinoma
  • Quick Look
    Hepatic Medicine: Evidence and Research
  • Quick Look
    Hepatic Encephalopathy
  • Quick Look
    Liver Fibrosis
  • Quick Look
    The Liver and Polycystic Kidney Disease
  • Quick Look
    Livers
  • Quick Look
    Hepatic Oncology
  • Quick Look
    Ultrasound Elastography
  • Quick Look
    iLIVER
  • Quick Look
    Advances in Treatment of Hepatitis C and B
  • Quick Look
    Journal of Renal and Hepatic Disorders
  • Quick Look
    Liver Cirrhosis
  • Quick Look
    Biliary Atresia: Aetiology, Diagnosis and Treatment
  • Quick Look
    NASH and Systemic Complications
  • Quick Look
    Chronic HCV Infection: Clinical Advances and Eradication Perspectives

Ngā kōwhiringa rapu

  • Hītori rapu
  • Rapu Whatutoto

Kimihia ētahi atu

  • Tirotirohia te Putumōhio Tūemi
  • Tirotiro ā-Arapū
  • Tūhurahura Hongere